guest ::
| Home > Publications database > Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity. > print |
| Home > Publications database > Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity. > print |
| 001 | 126219 | ||
| 005 | 20240228140815.0 | ||
| 024 | 7 | _ | |a 10.1093/hmg/ddv107 |2 doi |
| 024 | 7 | _ | |a pmid:25794683 |2 pmid |
| 024 | 7 | _ | |a 0964-6906 |2 ISSN |
| 024 | 7 | _ | |a 1460-2083 |2 ISSN |
| 024 | 7 | _ | |a altmetric:3815266 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2017-02334 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Butzlaff, Malte |b 0 |
| 245 | _ | _ | |a Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity. |
| 260 | _ | _ | |a Oxford |c 2015 |b Oxford Univ. Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1508403600_7026 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The gene mapt codes for the microtubule-associated protein Tau. The R406W amino acid substitution in Tau is associated with frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) characterized by Tau-positive filamentous inclusions. These filamentous Tau inclusions are present in a group of neurodegenerative diseases known as tauopathies, including Alzheimer's disease (AD). To gain more insights into the pathomechanism of tauopathies, we performed an RNAi-based large-scale screen in Drosophila melanogaster to identify genetic modifiers of Tau[R406W]-induced toxicity. A collection of RNAi lines, putatively silencing more than 7000 genes, was screened for the ability to modify Tau[R406W]-induced toxicity in vivo. This collection covered more than 50% of all protein coding fly genes and more than 90% of all fly genes known to have a human ortholog. Hereby, we identified 62 genes that, when silenced by RNAi, modified Tau-induced toxicity specifically. Among these 62 modifiers were three subunits of the Dynein/Dynactin complex. Analysis on segmental nerves of fly larvae showed that pan neural Tau[R406W] expression and concomitant silencing of Dynein/Dynactin complex members synergistically caused strong pathological changes within the axonal compartment, but only minor changes at synapses. At the larval stage, these alterations did not cause locomotion deficits, but became evident in adult flies. Our data suggest that Tau-induced detrimental effects most likely originate from axonal rather than synaptic dysfunction and that impaired retrograde transport intensifies detrimental effects of Tau in axons. In conclusion, our findings contribute to the elucidation of disease mechanisms in tauopathies like FTDP-17 or AD. |
| 536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Drosophila Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a Microtubule-Associated Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a tau Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a tau protein, Drosophila |2 NLM Chemicals |
| 650 | _ | 7 | |a Dyneins |0 EC 3.6.4.2 |2 NLM Chemicals |
| 700 | 1 | _ | |a Hannan, Shabab B |b 1 |
| 700 | 1 | _ | |a Karsten, Peter |b 2 |
| 700 | 1 | _ | |a Lenz, Sarah |b 3 |
| 700 | 1 | _ | |a Ng, Josephine |b 4 |
| 700 | 1 | _ | |a Voßfeldt, Hannes |b 5 |
| 700 | 1 | _ | |a Prüßing, Katja |b 6 |
| 700 | 1 | _ | |a Pflanz, Ralf |b 7 |
| 700 | 1 | _ | |a Schulz, Jörg B |b 8 |
| 700 | 1 | _ | |a Rasse, Tobias |0 P:(DE-He78)e9a603e8a132f8501ed78cf4995c246c |b 9 |u dkfz |
| 700 | 1 | _ | |a Voigt, Aaron |b 10 |
| 773 | _ | _ | |a 10.1093/hmg/ddv107 |g Vol. 24, no. 13, p. 3623 - 3637 |0 PERI:(DE-600)1474816-2 |n 13 |p 3623 - 3637 |t Human molecular genetics |v 24 |y 2015 |x 1460-2083 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:126219 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)e9a603e8a132f8501ed78cf4995c246c |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |2 G:(DE-HGF)POF3-300 |v Functional and structural genomics |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |a Allianz-Lizenz / DFG |0 StatID:(DE-HGF)0400 |2 StatID |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b HUM MOL GENET : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b HUM MOL GENET : 2015 |
| 920 | 1 | _ | |0 I:(DE-He78)B180-20160331 |k B180 |l Proteostase neurodegenerativer Erkrankungen |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B180-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|